Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$36.89
-0.1%
$41.53
$31.01
$50.21
$18.73B0.643.36 million shs6.25 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$128.37
+1.4%
$132.11
$74.75
$142.00
$51.05B1.232.99 million shs1.78 million shs
3M stock logo
MMM
3M
$97.15
+0.4%
$96.14
$71.12
$99.70
$53.76B14.77 million shs4.82 million shs
ResMed Inc. stock logo
RMD
ResMed
$216.98
-0.5%
$189.86
$132.24
$237.26
$31.88B0.641.34 million shs655,018 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-0.05%-8.11%-14.78%-5.36%-20.67%
DexCom, Inc. stock logo
DXCM
DexCom
+1.36%+3.24%-7.32%+6.13%+9.42%
3M stock logo
MMM
3M
+0.33%+5.84%+4.26%+2.41%-5.51%
ResMed Inc. stock logo
RMD
ResMed
-0.54%-0.50%+16.63%+13.09%-8.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.9666 of 5 stars
4.13.02.54.03.11.72.5
DexCom, Inc. stock logo
DXCM
DexCom
4.9626 of 5 stars
3.55.00.04.72.62.53.1
3M stock logo
MMM
3M
3.8671 of 5 stars
2.03.03.32.82.52.50.6
ResMed Inc. stock logo
RMD
ResMed
4.5438 of 5 stars
2.41.03.34.53.21.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.22
Hold$46.3025.51% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.93
Moderate Buy$141.6710.36% Upside
3M stock logo
MMM
3M
2.09
Hold$103.706.74% Upside
ResMed Inc. stock logo
RMD
ResMed
2.70
Moderate Buy$202.80-6.54% Downside

Current Analyst Ratings

Latest DXCM, MMM, RMD, and BAX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
3M stock logo
MMM
3M
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$98.00 ➝ $100.00
5/1/2024
3M stock logo
MMM
3M
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$78.00 ➝ $87.00
5/1/2024
3M stock logo
MMM
3M
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$98.00 ➝ $100.00
5/1/2024
3M stock logo
MMM
3M
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$110.00 ➝ $111.00
4/26/2024
DexCom, Inc. stock logo
DXCM
DexCom
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$151.00 ➝ $160.00
4/26/2024
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$144.00 ➝ $145.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$205.00 ➝ $200.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$187.00 ➝ $200.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$227.00 ➝ $238.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$224.00 ➝ $236.00
4/17/2024
3M stock logo
MMM
3M
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$118.00 ➝ $110.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$14.81B1.26$5.24 per share7.04$16.69 per share2.21
DexCom, Inc. stock logo
DXCM
DexCom
$3.62B14.09$2.10 per share61.21$5.65 per share22.72
3M stock logo
MMM
3M
$32.68B1.64$12.92 per share7.52$8.91 per share10.90
ResMed Inc. stock logo
RMD
ResMed
$4.22B7.55$7.77 per share27.94$31.52 per share6.88

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
$2.66B$5.207.0911.531.9817.79%18.97%4.87%7/25/2024 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$541.50M$1.5582.8257.312.1616.82%31.01%10.29%7/25/2024 (Estimated)
3M stock logo
MMM
3M
-$7.00B-$12.72N/A12.581.78-21.57%95.80%10.50%7/23/2024 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$897.56M$6.5133.3325.292.7020.91%24.43%15.70%8/1/2024 (Estimated)

Latest DXCM, MMM, RMD, and BAX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q1 2024
Baxter International Inc. stock logo
BAX
Baxter International
$0.61$0.65+$0.04$1.23$3.55 billion$3.59 billion    
4/30/2024Q1 2024
3M stock logo
MMM
3M
$2.10$2.39+$0.29$3.11$7.64 billion$8.00 billion      
4/25/2024Q1 2024
DexCom, Inc. stock logo
DXCM
DexCom
$0.27$0.32+$0.05$0.28$911.20 million$921.00 million    
4/25/2024Q3 24
ResMed Inc. stock logo
RMD
ResMed
$1.91$2.13+$0.22$2.22$1.17 billion$1.20 billion    
2/8/2024Q4 2023
Baxter International Inc. stock logo
BAX
Baxter International
$0.86$0.88+$0.02$1.28$3.81 billion$3.89 billion    
2/8/2024Q4 2023
DexCom, Inc. stock logo
DXCM
DexCom
$0.43$0.50+$0.07$0.38$1.02 billion$1.03 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$1.163.14%+6.70%22.31%N/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
3M stock logo
MMM
3M
$6.046.22%+0.68%N/A 67 Years
ResMed Inc. stock logo
RMD
ResMed
$1.920.88%+5.66%29.49%12 Years

Latest DXCM, MMM, RMD, and BAX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
ResMed Inc. stock logo
RMD
ResMed
Quarterly$0.480.88%5/8/20245/9/20246/13/2024
2/12/2024
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.292.88%2/29/20243/1/20244/1/2024
2/6/2024
3M stock logo
MMM
3M
quarterly$1.516.44%2/15/20242/16/20243/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.48
1.04
DexCom, Inc. stock logo
DXCM
DexCom
1.08
2.90
2.53
3M stock logo
MMM
3M
4.17
1.64
0.76
ResMed Inc. stock logo
RMD
ResMed
0.22
3.04
1.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
3M stock logo
MMM
3M
65.25%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.21%
DexCom, Inc. stock logo
DXCM
DexCom
0.41%
3M stock logo
MMM
3M
0.34%
ResMed Inc. stock logo
RMD
ResMed
1.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000507.83 million506.76 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
9,600397.68 million396.05 millionOptionable
3M stock logo
MMM
3M
85,000553.36 million551.48 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,140146.91 million145.13 millionOptionable

DXCM, MMM, RMD, and BAX Headlines

SourceHeadline
ResMed Inc. (NYSE:RMD) Receives Consensus Rating of "Moderate Buy" from AnalystsResMed Inc. (NYSE:RMD) Receives Consensus Rating of "Moderate Buy" from Analysts
americanbankingnews.com - May 4 at 2:20 AM
4 Safe Bets Amid Growing Concerns Over Delay in Rate Cuts4 Safe Bets Amid Growing Concerns Over Delay in Rate Cuts
zacks.com - May 3 at 9:46 AM
ResMed Third Quarter 2024 Earnings: Beats ExpectationsResMed Third Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 1 at 9:22 AM
ResMed Inc. (NYSE:RMD) Director Karen Drexler Sells 425 Shares of StockResMed Inc. (NYSE:RMD) Director Karen Drexler Sells 425 Shares of Stock
americanbankingnews.com - May 1 at 5:14 AM
ResMed Inc. (NYSE:RMD) Director Karen Drexler Sells 425 SharesResMed Inc. (NYSE:RMD) Director Karen Drexler Sells 425 Shares
insidertrades.com - May 1 at 5:00 AM
Sivik Global Healthcare LLC Buys New Position in ResMed Inc. (NYSE:RMD)Sivik Global Healthcare LLC Buys New Position in ResMed Inc. (NYSE:RMD)
marketbeat.com - April 30 at 9:13 PM
Insider Selling: ResMed Inc. (NYSE:RMD) Director Sells 425 Shares of StockInsider Selling: ResMed Inc. (NYSE:RMD) Director Sells 425 Shares of Stock
marketbeat.com - April 30 at 4:35 PM
Why ResMed (RMD) is a Top Momentum Stock for the Long-TermWhy ResMed (RMD) is a Top Momentum Stock for the Long-Term
zacks.com - April 30 at 10:56 AM
ResMed Triumphs in Q3 With Strong EarningsResMed Triumphs in Q3 With Strong Earnings
fool.com - April 30 at 10:50 AM
(RMD) - Analyzing ResMeds Short Interest(RMD) - Analyzing ResMed's Short Interest
benzinga.com - April 30 at 10:50 AM
ResMed (NYSE:RMD) Trading Down 3% Following Analyst DowngradeResMed (NYSE:RMD) Trading Down 3% Following Analyst Downgrade
americanbankingnews.com - April 30 at 1:16 AM
Top Stocks to Buy with Rising EPS Estimates After EarningsTop Stocks to Buy with Rising EPS Estimates After Earnings
zacks.com - April 29 at 6:21 PM
Looking for a Growth Stock? 3 Reasons Why ResMed (RMD) is a Solid ChoiceLooking for a Growth Stock? 3 Reasons Why ResMed (RMD) is a Solid Choice
zacks.com - April 29 at 1:47 PM
ResMed (NYSE:RMD)  Shares Down 3%  After Analyst DowngradeResMed (NYSE:RMD) Shares Down 3% After Analyst Downgrade
marketbeat.com - April 29 at 10:59 AM
Heres Why ResMed (RMD) is a Strong Growth StockHere's Why ResMed (RMD) is a Strong Growth Stock
zacks.com - April 29 at 10:46 AM
ResMed (NYSE:RMD) Price Target Raised to $238.00ResMed (NYSE:RMD) Price Target Raised to $238.00
americanbankingnews.com - April 29 at 5:20 AM
Needham & Company LLC Boosts ResMed (NYSE:RMD) Price Target to $236.00Needham & Company LLC Boosts ResMed (NYSE:RMD) Price Target to $236.00
americanbankingnews.com - April 29 at 5:20 AM
Why is the ResMed share price surging again and up 14% in two sessions?Why is the ResMed share price surging again and up 14% in two sessions?
msn.com - April 28 at 10:28 PM
ResMed Silences The DoubtersResMed Silences The Doubters
fnarena.com - April 28 at 10:28 PM
ResMed shares hit 10-month highs on earnings beat, weight-loss drug tailwindsResMed shares hit 10-month highs on earnings beat, weight-loss drug tailwinds
marketindex.com.au - April 28 at 10:28 PM
ResMed (NYSE:RMD) PT Raised to $200.00 at Royal Bank of CanadaResMed (NYSE:RMD) PT Raised to $200.00 at Royal Bank of Canada
americanbankingnews.com - April 28 at 5:56 AM
ResMed (NYSE:RMD) PT Lowered to $200.00ResMed (NYSE:RMD) PT Lowered to $200.00
americanbankingnews.com - April 28 at 5:20 AM
ResMed Inc. (RMD) Q3 2024 Earnings Call TranscriptResMed Inc. (RMD) Q3 2024 Earnings Call Transcript
seekingalpha.com - April 27 at 9:19 PM
ResMed Inc. (NYSE:RMD) Stake Increased by C WorldWide Group Holding A SResMed Inc. (NYSE:RMD) Stake Increased by C WorldWide Group Holding A S
marketbeat.com - April 27 at 5:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Baxter International logo

Baxter International

NYSE:BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
DexCom logo

DexCom

NASDAQ:DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
3M logo

3M

NYSE:MMM
3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota.
ResMed logo

ResMed

NYSE:RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.